Ultralife Corp (ULBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 06-2000 | 12-1999 | 06-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -10,242 | N/A | -7,085 | -2,930 |
| Depreciation Amortization | 1,910 | 2,038 | 1,030 | 2,205 | 1,110 |
| Accounts receivable | N/A | 56 | N/A | -779 | N/A |
| Other Working Capital | 550 | -451 | -1,010 | -3,218 | -1,720 |
| Other Operating Activity | 1,590 | -1,933 | 180 | 850 | 0 |
| Operating Cash Flow | $4,050 | $-10,532 | $200 | $-8,027 | $-3,540 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,910 | -2,946 | -1,700 | -3,427 | -2,140 |
| Purchase Of Investment | N/A | -74,171 | N/A | -94,417 | N/A |
| Sale Of Investment | N/A | 83,568 | N/A | 106,159 | N/A |
| Other Investing Activity | 3,310 | 0 | 4,240 | 0 | 7,320 |
| Investing Cash Flow | $400 | $6,451 | $2,540 | $8,315 | $5,180 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,423 | N/A | 115 | N/A |
| Debt Repayment | N/A | -91 | N/A | -40 | N/A |
| Common Stock Issued | N/A | 5,275 | N/A | N/A | N/A |
| Other Financing Activity | 220 | 0 | 3,610 | 0 | 0 |
| Financing Cash Flow | $220 | $9,607 | $3,610 | $75 | $0 |
| Exchange Rate Effect | N/A | -590 | N/A | -459 | -90 |
| Beginning Cash Position | N/A | 776 | N/A | 872 | 870 |
| End Cash Position | N/A | 5,712 | N/A | 776 | 2,410 |
| Net Cash Flow | $4,670 | $4,936 | $6,350 | $-96 | $1,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,050 | -10,532 | 200 | -8,027 | -3,540 |
| Capital Expenditure | N/A | -2,946 | N/A | -3,427 | N/A |
| Free Cash Flow | 4,050 | -13,478 | 200 | -11,454 | -3,540 |